Happy birthday BioRadon! – European Organisation for Research and Treatment of Cancer (EORTC)

Quoting European Organisation for Research and Treatment of Cancer (EORTC) on LinkedIn:

“Happy birthday BioRadon!

Today, we celebrate the second anniversary of the opening of this EORTC study investigating correlations between radon exposure at home and molecular alterations in patients with all stages of non-small cell lung cancer.

The BioRadon project has received funding from the European Commission, Ligue contre le cancer, Eli Lilly and Company, Novartis, BeiGene and AUREUS ARS ET SCIENTIA ASBL.

Bioradon is a SPECTA platform downstream project. The SPECTA platform is supported by Alliance Healthcare, a member of Cencora.”

For more information click here.
Source: European Organisation for Research and Treatment of Cancer (EORTC)/LinkedIn.